Actively Recruiting
Effects of Remote Ischaemic Preconditioning in Cemented Hip Arthroplasty.
Led by University of Tartu · Updated on 2024-04-04
200
Participants Needed
1
Research Sites
153 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Bone cement implantation syndrome is associated with cemented hip arthroplasty and it has been shown to increase cardiovascular and renal complication and brain damage postoperatively. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients.
CONDITIONS
Official Title
Effects of Remote Ischaemic Preconditioning in Cemented Hip Arthroplasty.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 65 years
- Scheduled to undergo total cemented hip arthroplasty
You will not qualify if you...
- Previously diagnosed peripheral artery disease in both upper limbs
- Condition where remote ischemic preconditioning is contraindicated
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Tartu
Tartu, Tartu, Estonia, 50406
Actively Recruiting
Research Team
K
Kaspar Tootsi, PhD
CONTACT
K
Kaarel Ernits, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here